Recent studies have proposed a diagnostic algorithm to comprehensively analyze the optimal time points, amyloid proteins of PET biomarkers, tau, and genetic markers for the early diagnosis of AD, enabling a comprehensive study of the pathogenesis of the disease (3). Here, MAPT is linked to Alzheimer disease.